US 11266694
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted A61KA61K2239/57A61K40/11
Quick answer
US patent 11266694 (Restimulation of cryopreserved tumor infiltrating lymphocytes) held by Iovance Biotherapeutics, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2239/57, A61K40/11, A61K40/4271, A61P